F10 and cancer: The coagulation mechanism of CRS may be mediated by a factor Xa‐independent pathway. There are many complex and undiscovered mechanisms of CRS; it is necessary to further explore the molecular mechanism of CRS hypercoagulability and determine the best strategies for stroke prevention in cancer patients. Experimental data on secondary prevention comparison of CRS in recent years are summarized in Table 2.